Super ED Trial Pack

Super ED Trial Pack combines three potent and popular drugs for erectile dysfunction – Viagra 100 mg, Cialis 20 mg, and Levitra 20 mg. All three drugs are PDE5 inhibitors that improve an erection for longer sexual intercourse.

Indications

These medications are effective regulators of potency. They significantly improve the sexual function of men. The safety of the drugs has been thoroughly investigated and clinically proven. These tablets increase the concentration of cyclic guanosine monophosphate at the time of sexual arousal. In this case, the smooth arterial muscles relax and are filled with a large flow of blood. As a result, a man gets a hard and lasting erection. The drugs are successfully used by men who have varying degrees of erectile dysfunction. The etiology of such deviations can also be different – both psychogenic and organic.

The drugs are intended for oral use. The dosage is determined by a doctor.

Cialis is taken at least 30 minutes before the planned sexual intercourse. The recommended dose is 10 mg taken once a day. The effect occurs after 15-16 minutes and lasts 36 hours. This drug is not intended for systemic daily use. With frequent use (2 times a week), you’d better take low dosages – 5 mg.

Levitra is taken 25 to 60 minutes before sexual activity. The recommended dose is 20 mg taken once a day. Depending on the effect and tolerability, the dose can be increased up to 20 mg or reduced up to 5 mg. The effect occurs in about 30 minutes and lasts 5 hours.

Viagra is taken an hour before sexual activity. The standard single dose is 50 mg (preferably on an empty stomach). The maximum single dose is 100 mg. The effect occurs in about 30-60 minutes and lasts 4 hours.

All three drugs are contraindicated in cases where the patient has a pronounced hypersensitivity (allergy) to the active ingredient or auxiliary components on the drug.

The use is contraindicated in the presence of cardiovascular diseases, in particular:

• myocardial infarction, angina pectoris;
• arrhythmias, arterial hypotension, uncontrolled hypertension;
• a stroke;
• loss of one of the eyes due to neuropathy.

• Neurological disorders: headache, flushing, migraine, ataxia, tremor, weakening reflexes, neuralgia, paresthesia, hypesthesia, depression, fainting, insomnia/drowsiness, dizziness;
• Ophthalmic disorders: visual impairment (hypersensitivity to light, a change in color perception, blurred vision), conjunctivitis, mydriasis, cataracts, hemorrhages in the eyeball, pain in the eyeballs, xerophthalmia;
• Otolaryngological disorders: deafness, tinnitus;
• Respiratory disorders: nasal congestion, pharyngitis, bronchitis, sinusitis, laryngitis, dyspnea, increased cough, increased sputum, bronchial asthma;
• Cardiovascular disorders: arterial hypotension, tachycardia, orthostatic hypotension, palpitations, angina pectoris, myocardial ischemia, cardiomyopathy, ECG changes, heart failure, AV block, cerebral vascular thrombosis, cardiac arrest;
• Hematologic disorders: anemia, leukopenia;
• Gastrointestinal disorders: glossitis, stomatitis, gingivitis, dry mouth, nausea, dysphagia, esophagitis, gastritis, colitis, gastroenteritis, rectal bleeding;
• Metabolic disorders: thirst, hyperuricemia, hypernatremia, gout, labile diabetes, hyper/hypoglycemia;
• Genitourinary disorders: urinary tract infections, nocturia, cystitis, frequent urination, urinary incontinence, anorgasmia, impaired ejaculation, gynecomastia, genital edema;
• Musculoskeletal disorders: arthritis, myalgia, arthrosis, tendon rupture, myasthenia gravis, synovitis, tendosynovitis;
• Dermatological disorders: contact dermatitis, rash, urticaria, pruritus, herpes simplex, skin ulceration, exfoliative dermatitis, photosensitivity;
• Other: peripheral edema, pain, sweating, chills, shock, allergic reactions.

Drugs from Super ED Trial Pack can interact with the following medications:

• Alpha-adrenergic blocking agents used to treat hypertension and prostate diseases. Simultaneous administration can lead to a significant decrease in blood pressure. Representatives of the alpha-adrenergic blocking group: Tamsulosin, Terazosin, Doxazosin, etc.;
• Cytochrome P-450 Inhibitors. When used together, the concentration of the PDE-5 inhibitor in the blood can increase or decrease uncontrollably. Representatives: erythromycin, azithromycin, ketoconazole, itraconazole, as well as grapefruit juice;
• Inductors of cytochrome P-450. When combined with these drugs, the concentration of Sildenafil, Tadalafil and Vardenafil in the blood can sharply decrease. Representatives: Pentobarbital, Phenobarbital, Carbamazepine, Rifampicin, Phenytoin, etc.;
• HIV protease inhibitors. Co-administration of drugs leads to a significant increase in the concentration of PDE-5 inhibitors in the blood and an increase in the frequency of complications. Representatives: ritonavir, indinavir.